Menu
← Oncology Approval Tracker
FDA DECISION ·
Ryoncil
remestemcel-L-rknd · Mesoblast
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Children aged 2 months and older with steroid-refractory acute graft-versus-host disease.
LAMPGEN ANALYSIS
Why it matters
The allogeneic mesenchymal stromal cell product adds a pediatric rescue option for a serious complication of stem cell transplantation.
What research teams should watch
Record steroid start, dose and response, and coordinate cellular product receipt and infusion with the transplant unit.
PRIMARY RECORDS